Tear Duct Obstruction – A Complete Patient Guide

Overview

A tear duct (or nasolacrimal) obstruction occurs when the tiny channel that drains tears from the eye’s surface into the nose becomes partially or completely blocked. When tears cannot drain properly, they pool on the eye, leading to watery eyes, irritation, and, in some cases, infection.

Who it affects: The condition can appear at any age, but the two most common groups are:

• Infants and young children – congenital (present at birth) blockage accounts for roughly 6–9 % of newborns.¹
• Adults – acquired blockage often develops after age 40 and is more frequent in women.^2

Prevalence: In the United States, an estimated 6‑9 % of newborns have a congenital tear‑duct obstruction, while about 1‑2 % of adults experience an acquired form during their lifetime.^3

Symptoms

The clinical picture varies with the degree of blockage (partial vs. complete) and whether infection is present. Common symptoms include:

• Excessive tearing (epiphora): Constant or intermittent watery discharge that overflows onto the cheek.
• Sticky or mucous discharge: Especially with a partial blockage, tears mix with mucus and may be thick.
• Redness and irritation: The conjunctiva (white part of the eye) may appear pink.
• Crusting around the inner corner (medial canthus): Often noticeable upon waking.
• Pain or pressure: More frequent if an infection (dacryocystitis) develops.
• Recurrent eye infections (conjunctivitis): Because stagnant tears become a breeding ground for bacteria.
• Swelling of the lacrimal sac: A tender, red bump near the inner eye can be a sign of acute blockage.
• Blurred vision: Rare, but excessive tearing can temporarily disturb visual clarity.

Causes and Risk Factors

Congenital (present at birth)

• Failure of the nasolacrimal duct to open during fetal development.
• Associated with certain syndromes (e.g., Down syndrome, Turner syndrome).

Acquired (develops later in life)

• Age‑related changes: Tissue scarring or narrowing of the duct.
• Inflammation or infection: Chronic sinusitis, recurrent conjunctivitis, or previous dacryocystitis.
• Trauma: Facial fractures, eyelid surgery, or punctal plugs that damage the duct.
• Tumors: Benign growths (e.g., dacryocystocele) or malignancies near the lacrimal sac.
• Systemic diseases: Granulomatosis with polyangiitis, sarcoidosis, and rheumatoid arthritis can cause scarring.

Risk Factors

• Female sex (higher incidence in post‑menopausal women).
• History of sinus disease or chronic allergies.
• Previous eye or facial surgery.
• Smoking (increases inflammation and scarring).
• Genetic predisposition for congenital blockage.

Diagnosis

Diagnosis is usually clinical, but several specialized tests help confirm the blockage and its location.

History & Physical Exam

• Detailed symptom timeline and any previous infections or surgeries.
• Observation of tear overflow, discharge, and eyelid position.

Fluorescein Dye Test (Jones Test)

A drop of fluorescein dye is placed in the eye. The dye is observed through a Wood’s lamp to see if it drains into the nasal cavity (visible as a green stream in the back of the nose). Lack of drainage suggests obstruction.

Nasolacrimal Duct Probing & Irrigation

A thin probe is gently threaded through the puncta (tiny openings on the eyelid margins) into the duct. Saline is flushed to assess patency and to clear mucus.

Imaging (when indicated)

• CT or MRI: Evaluate sinonasal disease, tumors, or bony abnormalities.
• Dacryocystography: X‑ray contrast study of the lacrimal drainage system.

Microbiological Culture

If infection is suspected, a sample of discharge is cultured to guide antibiotic therapy.

Treatment Options

Management depends on the age of the patient, severity of obstruction, and presence of infection.

Conservative Measures (often first‑line in infants)

• Gentle lacrimal sac massage (Crigler massage): Performed 5‑10 minutes, several times a day, to help open the duct.
• Warm compresses: Relieve swelling and improve tear flow.
• Cleaning the inner eye corner: Use a warm, damp cloth to remove crusting.
• Most congenital blockages resolve spontaneously by 12 months; persistent cases may need intervention.

Medical Therapy (when infection is present)

• Topical antibiotics: Erythromycin ointment or fluoroquinolone drops.
• Oral antibiotics: Amoxicillin‑clavulanate for moderate‑to‑severe dacryocystitis.
• Anti‑inflammatory eye drops: Short‑term use of steroid‑containing drops can reduce edema.

Procedural Options

1. Lacrimal Duct Probing

Usually performed under topical anesthesia in children >6 months and in adults with partial obstruction. A thin metal probe clears the blockage; success rates are 70‑90 % in children and ~60 % in adults.

2. Balloon Dacryocystoplasty

A small balloon catheter is inserted and inflated to expand the duct. It offers a less invasive alternative to surgery, with success rates of 60‑80 %.

3. Silicone Stent Placement

After probing, a tiny silicone tube (often 3–6 mm) is left in place for 3–6 months to keep the duct open, especially in recurrent cases.

4. Endoscopic Dacryocystorhinostomy (DCR)

Considered the gold‑standard for chronic, complete obstruction in adults. An endoscopic approach creates a new opening between the lacrimal sac and the nasal cavity, bypassing the blocked duct. Success rates range from 90‑95 % with a low complication profile.

5. External DCR

Traditional “skin‑incision” surgery; still used when endoscopic equipment isn’t available. Comparable success but a small external scar.

Lifestyle & Home Care

• Maintain eyelid hygiene – clean daily with warm water.
• Avoid eye rubbing, which can worsen inflammation.
• Use preservative‑free artificial tears if dry‑eye symptoms coexist.
• Control allergies with antihistamines or intranasal steroids to reduce secondary swelling.

Living with Tear Duct Obstruction

Even after successful treatment, some individuals experience intermittent tearing. The following strategies help manage daily life:

• Protect cosmetics: Use water‑based eye makeup and remove thoroughly each night.
• Wear goggles in windy or dusty environments: Reduces tear evaporation and irritation.
• Adjust computer screens: Blink regularly and consider a humidifier to keep ocular surface moist.
• Regular ophthalmology follow‑up: Once a year, or sooner if symptoms recur.
• Mindful diet: Stay hydrated; omega‑3 fatty acids (found in fish oil) may improve tear film quality.

Prevention

While congenital blockage cannot be prevented, many acquired risk factors are modifiable:

• Manage chronic sinusitis and allergies promptly.
• Avoid smoking and limit exposure to second‑hand smoke.
• Use protective eyewear during activities that could cause facial trauma.
• Practice good eyelid hygiene, especially for individuals with blepharitis.
• Seek timely treatment for eye infections to prevent scarring.

Complications

If left untreated, tear‑duct obstruction can lead to:

• Dacryocystitis: Painful infection of the lacrimal sac; may progress to abscess formation.
• Orbital cellulitis: Rare spread of infection into the orbital tissues – a medical emergency.
• Chronic conjunctivitis: Persistent inflammation due to tear stagnation.
• Skin irritation: Constant moisture can cause dermatitis around the eye.
• Reduced quality of life: Ongoing tearing may affect work, social interactions, and self‑esteem.

When to Seek Emergency Care

© 2026 HealthGuide™ – All information provided is for educational purposes and does not replace professional medical assessment. For personalized advice, please consult an ophthalmologist or qualified healthcare provider.

References

1. Mayo Clinic. “Congenital nasolacrimal duct obstruction.” 2023.
2. American Academy of Ophthalmology. “Nasolacrimal Duct Obstruction in Adults.” 2022.
3. Centers for Disease Control and Prevention. “Birth Defects and Congenital Anomalies.” 2021.
4. Cleveland Clinic. “Tear Duct Obstruction (Blocked Tear Duct).” 2024.
5. World Health Organization. “Eye health: Common ocular conditions.” 2022.
6. JAMA Ophthalmology. “Outcomes of Endoscopic Dacryocystorhinostomy versus External DCR.” 2021;139(5):567‑575.